Search
Totrombopag
go.drugbank.com/drugs/DB05930InvestigationalThis drug is developed by GlaxoSmithKline and used to treat Thrombocytopenia.Thrombocytopenia (decreased platelet count) is a common side effect of many chemotherapies and can lead to uncontrolled bleeding
Phencyclidine
go.drugbank.com/drugs/DB03575ExperimentalIllicitLike ketamine, it can produce a dissociative state. It exerts its pharmacological action through inhibition of NMDA receptors (receptors, N-methyl-D-aspartate).
Categories: Cytochrome P-450 CYP2B6 Inhibitors, Cytochrome P-450 Enzyme InhibitorsDichlorophen
go.drugbank.com/drugs/DB11396InvestigationalVet approvedDichlorophen is an antimicrobial agent shown to exert activity against cestodes, protozoa, fungi, and bacteria.
MT-0169
go.drugbank.com/drugs/DB17430InvestigationalMT-0169 is a usion protein comprised of an enzymatically active Shiga-like toxin-I A1 subunit fused to a human single chain variable fragment with affinity for human CD38 cell surface protein.
Exbivirumab
go.drugbank.com/drugs/DB17747ExperimentalExbivirumab is an investigational monoclonal antibody.
AMP-101
go.drugbank.com/drugs/DB18253ExperimentalAMP-101 is a gene therapy comprising an adeno-associated virus type 9 (AAV9) vector encoding the human Dok-7 protein. It is under investigation for the treatment of Dok-7-associated myasthenia.
ICX-RHY
go.drugbank.com/drugs/DB05716ExperimentalICX-RHY is an investigational therapy comprised of cultured allogeneic fibroblasts.
16-Bromoepiandrosterone
go.drugbank.com/drugs/DB05107Investigational16-Bromoepiandrosterone is an injectable formulation of a compound called alpha-epi-bromide.
Velufenacin
go.drugbank.com/drugs/DB21473InvestigationalVelufenacin has a monoisotopic molecular weight of 362.12 Da. … Velufenacin is under investigation in clinical trial NCT05282069 (A Study to Evaluate the Efficacy and Safety of DA-8010 in Patients With Overactive Bladder).